Surrey Heartlands

Joint Formulary & PAD

Somatropin - Growth failure - children

You are here : Home > Formulary Search > Somatropin - Growth failure - children

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Amber
Formulations :
  • Subcutaneous injection (sc)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
ICB
NICE
Restrictions / Comments :
Documents :
 
Shared Care
Paediatric growth hormone shared care document Jun24.pdf

Documentation

NICE Technology Appraisal
NICE TA188 - Somatropin for Growth Failure in Children

PAD Profile

ChemicalSubstance :
Somatropin
Indication :
Growth failure - children
Group Name :
Keywords :
Turner syndrome, growth hormone deficiency, born small for gestational age, short stature, Gonadal dysgenesis
Brand Names Include :
Genotropin, Norditropin FlexPro Omnitrope, Saizen, Zomacton
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2

Other Indications

Below are listed other indications that Somatropin is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Growth failure - children.

Committee Recommendations (1)

07 Aug 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed the reviewed AMBER shared care document for Recombinant human growth hormone for children and young people.